Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02564029 : PF-06372865 in Subjects With Photosensitive Epilepsy
PhasePhase 2
AgesMin: 18 Years Max: 60 Years
Eligibility
Inclusion Criteria:

- A diagnosis and history of photoparoxysmal response on electroencephalogram (EEG)
with or without a diagnosis of epilepsy for which subjects are taking up to 0 - 2
concomitant antiepileptic drugs.

- Subjects currently taking antiepileptic drug(s) to be on a stable dose for 4 weeks
prior to Screening Visit.

- A minimum average standardized photosensitive range (SPR) across all screening
timepoints of 4 in the most sensitive eye condition and a non-zero average in at
least one other eye condition.

Exclusion Criteria:

- Subjects with a history of status epilepticus.

- Subjects who have experienced a generalized tonic-clonic convulsion in the past 6
months, at the time of the initial screening visit.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02564029      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740